000 01817nam##2200349za#4500
0019.654005
003CaOODSP
00520200330131008
007ta
008150407|1991||||xxc|||||     f|0| 0 eng|d
020 |a0-662-58141-5
040 |aCaOODSP|beng
041 |aeng
041 |afre
043 |an-cn---
0861 |aH42-2/48-1991
1101 |aCanada.|bHealth and Welfare Canada. |bHealth Protection Branch.
24510|aManagement of Kaposi's sarcoma associated with human immunodeficiency virus infection / |cby Frances A. Shepherd. Issued by Drugs Directorate.
260 |aOttawa - Ontario : |bHealth and Welfare Canada. |c1991.
300 |aEnglish text, 16, 4p. : |bcoloured illus., references ; |c28 cm.
500 |a"This report briefly discusses the etiology and diagnosis of Kaposi's sarcoma. It also describes the variations in the clinical presentation of the disease and the treatment strategies common to all KS patients."--Page 1.
5203 |aThis report briefly discusses the etiology and diagnosis of Kaposi's sarcoma. It also describes the variations in the clinical presentation of the disease and the treatment strategies common to all KS patients.--Page 1
546 |aBilingual
563 |aSoftcover
590 |a91-28|b1991-07-12
69007|aDiseases|2gcpds
69007|aInfectious diseases|2gcpds
69007|aAIDS (disease)|2gcpds
7201 |aShepherd, Frances A.
7760#|tTraitement du sarcome de Kaposi associé à l'infection due au virus de l'immunodéficience humaine : |w(CaOODSP)9.639926
7760#|tManagement of Kaposi's sarcoma associated with human immunodeficiency virus infection : |w(CaOODSP)9.695824
792 |tTraitement du sarcome de Kaposi associé à l'infection due au virus de l'immunodéficience humaine / |w(CaOODSP)9.654006